Form 8-K - Current report:
SEC Accession No. 0001493152-23-032160
Filing Date
2023-09-11
Accepted
2023-09-08 19:41:06
Documents
13
Period of Report
2023-09-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45556
2 ex3-1.htm EX-3.1 189165
  Complete submission text file 0001493152-23-032160.txt   454741

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnxt-20230907.xsd EX-101.SCH 3015
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnxt-20230907_lab.xml EX-101.LAB 34916
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnxt-20230907_pre.xml EX-101.PRE 22789
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3657
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 231246453
SIC: 2834 Pharmaceutical Preparations